U. Lüning et al.
FULL PAPER
3
for receptor 1a, from N,NЈ-bis(6-aminopyrid-2-yl)-4,6-dibromo-
isophthalamide (6c, 450 mg, 0.889 mmol), triethylamine (2.00 mL,
9.09 mmol), and pentanoyl chloride (433 μL, 3.56 mmol) in anhy-
drous tetrahydrofuran (10 mL). The residue was purified by column
chromatography (silica gel, ethyl acetate/cyclohexane 1:1, Rf =
COCH2CH2), 1.32 (sext, JH,H = 7.5 Hz, 4 H, COCH2CH2CH2),
0.86 (t, JH,H = 7.3 Hz, 6 H, CH3) ppm. 13C NMR (125 MHz,
3
CDCl3): δ = 172.1 (s, CH3CH2CH2CH2CO), 166.1 (s, NHCO),
150.5 (s, Ar-C-5), 150.3 (s, Py-C-2), 139.9 (Py-C-6, Py-C-4), 135.1
(s, Ar-C-1,3), 119.5 (Ar-C-4,6, Ar-C-2), 110.1 (d, Py-C-3), 109.4 (d,
Py-C-5), 35.8 (t, COCH2), 27.1 (t, COCH2CH2), 21.7 (t, CH2CH3),
1
0.39); yield 475 mg (70%); m.p. 199–201 °C. H NMR (200 MHz,
CDCl3): δ = 8.47 (br. s, 2 H, Ar-CONH), 8.05 (br. s, 1 H, Ar-H-
13.7 (q, CH ) ppm. IR (KBr): ν = 3376 (O–H, N–H), 1654 (C=O),
˜
3
5), 7.83 (s, 1 H, Ar-H-2), 8.20 (br. s, 2 H, H9C4CONH), 7.93 (d, 2 1585, 1530 (arom.), 1293 (N–H) cm–1. MS (ESI): m/z (%) = 533 [M
H, Py-5-H), 7.86 (br. d, 4 H, Py-3-H), 7.61 (t, 3JH,H = 8.2 Hz, 2 H,
+ H]+, 555 [M + Na]+. C28H32N6O5 (532.6): calcd. C 63.14, H 6.06,
3
3
Py-4-H), 2.38 (t, JH,H = 7.5 Hz, 4 H, COCH2), 1.68 (quin, JH,H N 15.78. C28H32N6O5·0.5H2O: calcd. C 62.05, H 6.14, N 15.52;
3
= 7.5 Hz, 4 H, COCH2CH2), 1.37 (sext, JH,H = 7.4 Hz, 4 H, found C 61.85, H 6.15, N 15.59.
CH2CH3), 0.91 (t, JH,H = 7.4 Hz, 6 H, CH2CH3) ppm. 13C NMR
3
N,NЈ-Bis[6-(2-ethylhexanoylamino)pyrid-2-yl]-5-iodoisophthalamide
(125 MHz, CDCl3): δ = 172.2 (s, COC4H9), 164.0 (s, Ar-CONH),
(2a): Compound 2a was synthesized by the same procedure as used
150.0 (s, Py-C-2), 148.5 (s, Py-C-6), 141.0 (d, Py-C-4), 137.9 (s, Ar-
for receptor 1a, from N,NЈ-bis(6-aminopyrid-2-yl)-5-iodoisophthal-
C-4,6), 136.2 (s, Ar-C-1,3), 130.3 (d, Ar-C-5), 122.1 (d, Ar-C-2),
amide (6a, 1.23 g, 2.60 mmol), triethylamine (750 μL, 5.50 mmol),
110.6 (d, Py-C-3), 109.8 (d, Py-C-5), 37.6 (t, COCH2), 27.4 (t,
and 2-ethylhexanoyl chloride (950 μL, 5.50 mmol). Column
COCH CH ), 22.3 (t CH CH ), 13.8 (q, CH ) ppm. IR (ATR): ν
˜
2
2
2
3
3
chromatography (silica gel, ethyl acetate/cyclohexane 1:1, Rf
=
= 3289 (N–H), 3025 (arom. C–H), 2958, 2930, 2871 (aliph. C–H),
1674 (C=O), 1582, 1505 (arom. C=C), 1445 (CH2, CH3) 1052
(arom. C–Br) cm–1. MS (EI, 70 eV): m/z (%) = 672 (5) [M]+·, 615
(8) [M – C4H9]+. MS (MALDI): m/z = 673 [M + H]+, 695 [M +
Na]+, 711 [M + K]+. C28H30Br2N6O4 (674.38): calcd. C 49.87, H
4.48, N 12.46; found C 49.67, H 4.53, N 12.25.
0.59); yield 1.51 g (80%); m.p. 130–132 °C. 1H NMR (500 MHz,
CDCl3): δ = 8.40 (br. s, 2 H, Ar-CONH), 8.40–8.35 (m, 3 H, Ar-
3
H-2,4,6), 8.03, 7.97 (2ϫd, JH,H = 8.0 Hz, 4 H, Pyr-3,5-H), 7.90
3
(br. s, 2 H, H15C7CONH), 7.73 (t, JH,H = 8.0 Hz, 2 H, Py-4-H),
2.19 (mc, 2 H, COCH), 1.80–1.50 (m, 8 H, COCHCH2), 1.32 (mc,
3
8 H, CH2CH2CH3), 0.97 (t, JH,H = 7.4 Hz, 6 H, CHCH2CH3)
5-Benzoyloxy-N,NЈ-bis[6-(pentanoylamino)pyrid-2-yl]isophthalamide
(1d): N-(6-Aminopyrid-2-yl)pentanamide (7, 1.12 g, 6.18 mmol)
0.88 (mc, 6 H, CHCH2CH2CH2CH3) ppm. 13C NMR (150 MHz,
CDCl3): δ = 174.9 (s, COC7H15), 162.8 (s, Ar-CONH), 149.8 (s,
and anhydrous triethylamine (1.12 mL, 8.03 mmol) were dissolved Py-C-2), 148.9 (s, Py-C-6), 141.0 (d, Py-C-4), 139.6 (d, Ar-C-2),
in anhydrous tetrahydrofuran (60 mL) under nitrogen. A solution 136.3 (s, Ar-C-1,3), 125.0 (d, Ar-C-4,6), 110.5 (d, Py-C-3), 109.7
of 5-(benzoyloxy)isophthaloyl chloride (9, 1.00 g, 2.37 mmol) in an- (d, Py-C-5), 94.8 (s, Ar-C-5), 50.7 (d, COCH), 32.4 (t,
hydrous tetrahydrofuran (15 mL) was then added dropwise. After
the system had been stirred at room temp. for 30 min it was heated
to reflux for 18 h. The resulting dispersion was filtered and the
solvent was evaporated in vacuo. The residue was purified by col-
umn chromatography (silica gel, ethyl acetate/cyclohexane 3:2, Rf
= 0.8); yield 911 mg (60%); m.p. 115 °C. 1H NMR (300 MHz,
CH2CH2CH2CH3), 29.8 (t, CH2CH2CH2CH3), 26.1 (t,
CHCH2CH3), 22.8 (t, CH2CH2CH2CH3), 14.0 (q,
CH CH CH CH ), 12.0 (q, CHCH CH ) ppm. IR (ATR): ν =
˜
2
2
2
3
2
3
3279 (N–H), 3071 (arom. C–H), 2958, 2929, 2859 (aliph. C–H),
1668 (C=O), 1580, 1504 (arom. C=C), 1441 (alkyl C–H) cm–1. MS
(EI, 70 eV): m/z (%) = 726 (15) [M]+·, 670 (72) [M – C4H8]+·, 627
(100) [M – C7H15]+, 600 (5) [M – I]+·. MS (CI, isobutane): m/z (%)
= 727 (100) [M + H]+, 601 (18) [M – I + H]+. MS (ESI): m/z (%)
= 727 [M + H]+. MS (MALDI): m/z (%) = 727 [M + H]+, 749 [M
+ Na]+, 765 [M + K]+. C34H43IN6O4 (726.24): calcd. C 56.20, H
5.96, N 11.57; found C 56.20, H 6.13, N 11.60.
3
CDCl3): δ = 8.22 (s, 1 H, Ar-H-2), 8.21 (d, JH,H = 8.1 Hz, 2 H,
Py-H-5), 8.05–7.94 (m, 6 H, Ar-H-4,6, Bz-H-2,6, Py-H-3), 7.81–
7.74 (m, 2 H, Bz-H-3,5), 7.70 (t, 3JH,H = 7.5 Hz, 1 H, Bz-H-4), 7.56
3
3
(t, JH,H = 8.1 Hz, 2 H, Py-H-4), 2.38 (t, JH,H = 7.5 Hz, 4 H,
3
COCH2), 1.73 (quint, JH,H = 7.5 Hz, 4 H, COCH2CH2), 1.42
(sext, JH,H = 7.5 Hz, 4 H, COCH2CH2CH2), 0.96 (t, JH,H
3
3
=
N,NЈ-Bis[6-(2-ethylhexanoylamino)pyrid-2-yl]-5-nitroisophthalamide
(2b): Compound 2b was synthesized by the same procedure as used
for receptor 1a, from N,NЈ-bis(6-aminopyrid-2-yl)-5-nitroiso-
phthalamide (6b, 661 mg, 1.68 mmol), triethylamine (785 μL,
3.56 mmol), and 2-ethylhexanoyl chloride (615 μL, 3.56 mmol).
The crude product was purified by column chromatography (silica
gel, cyclohexane/ethyl acetate 1:1, Rf = 0.60); yield 500 mg (46%)
as a slightly yellow solid; m.p. 119–121 °C. 1H NMR (500 MHz,
7.3 Hz, 6 H, CH3), ppm. 13C NMR (75.5 MHz, CDCl3): δ = 172.1
(s, NHCO), 165.1 (s, NHCO), 163.7 (s, OCO), 151.5 (s, Ar-C-5),
150.0 (s, Py-C-2), 149.1 (s, Py-C-6), 140.9 (d, Py-C-4), 136.1 (s, Ar-
C-1,3), 134.3 (d, Bz-C-4), 130.3 (s, Bz-C-1), 128.8 (d, Bz-C-2,6),
128.3 (d, Bz-C-3,5), 125.0 (d, Ar-C-4,6), 122.9 (d, Ar-C-2), 110.3
(d, Py-C-3), 109.4 (d, Py-C-5), 37.4 (t, CH2), 27.4 (t, CH2), 22.4 (t,
CH ), 13.8 (q, CH ) ppm. IR (KBr): ν = 3408 (N–H), 2962 (aliph.
˜
2
3
C–H), 1686 (C=O), 1584, 1523 (arom.), 1260 (N–H) cm–1. MS
(ESI): m/z (%) = 637 [M + H]+, 659 [M + Na]+. C35H36N6O6
(636.7): calcd. C 66.02, H 5.70, N 13.20. C41H48N6O6·2.5H2O:
calcd. C 61.66, H 6.06, N 12.33; found C 61.81, H 6.04, N 12.23.
4
CDCl3): δ = 8.87 (d, JH,H = 1.5 Hz, 2 H, Ar-H-4,6), 8.83 (t, 4JH,H
= 1.5 Hz, 1 H, Ar-H-2), 8.76 (br. s, 2 H, Ar-CONH), 8.02 (d, 3JH,H
= 8.0 Hz, 2 H, Pyr-5-H), 7.99 (br. s, 2 H, H9C4CONH), 7.95 (d,
3
3JH,H = 8.0 Hz, 2 H, Pyr-3-H), 7.74 (t, JH,H = 8.0 Hz, 2 H, Py-4-
5-Hydroxy-N,NЈ-bis[6-(pentanoylamino)pyrid-2-yl]isophthalamide
H), 2.21 (mc, 2 H, COCH), 1.80–1.50 (m, 8 H, COCHCH2), 1.32
3
(1e):
5-Benzoyloxy-N,NЈ-bis[6-(pentanoylamino)pyrid-2-yl]iso-
(mc, 8 H, CH2CH2CH3), 0.97 (t, JH,H = 7.5 Hz, 6 H, CHCH2-
phthalamide (1d, 570 mg, 896 μmol) was dissolved in ethanol
(5 mL). After addition of sodium hydroxide (1 n, 10 mL), the solu-
tion was stirred for 3 h and then acidified with hydrochloric acid
(2 n). The mixture was filtered, and the solid was washed with
tetrahydrofuran. The organic filtrate was dried with sodium sulfate
and the solvent was evaporated in vacuo; yield 449 mg (94%); m.p.
172 °C. 1H NMR (300 MHz, [D6]DMSO): δ = 10.4 (br. s, 2 H,
CH3), 0.88 (t, 3JH,H = 6.9 Hz, 6 H, CHCH2CH2CH2CH3) ppm. 13
C
NMR (125 MHz, CDCl3): δ = 175.1 (s, COC7H15), 162.1 (s, Ar-
CONH), 149.9 (s, Py-C-2), 148.8 (s, Py-C-6), 148.7 (s, Ar-C-5),
141.0 (d, Py-C-4), 141.0 (d, Ar-C-2), 136.5 (s, Ar-C-1,3), 125.3 (d,
Ar-C-4,6), 110.8 (d, Py-C-3), 109.8 (d, Py-C-5), 50.7 (d, COCH),
32.4 (t, CH2CH2CH2CH3), 29.8 (t, CH2CH2CH2CH3), 26.1 (t,
CHCH2CH3),
22.8
(t,
CH2CH2CH2CH3),
14.0
(q,
CONH), 10.2 (br. s, 2 H, CONH), 8.00 (s, 1 H, Ar-H-2), 7.52 (s, 2 CH CH CH CH ), 12.0 (q, CHCH CH ) ppm. IR (ATR): ν =
˜
2
2
2
3
2
3
3
H, Ar-H-4,6), 7.86–7.75 (m, 6 H, Py-H-3,4,5), 2.41 (t, JH,H
=
H,
3283 (N–H), 3050 (arom. C–H), 2959, 2931, 2872 (aliph. C–H),
3
7.4 Hz,
2
H, COCH2), 1.58 (quint, JH,H
=
7.4 Hz,
4
1669 (C=O), 1583, 1505 (arom. C=C), 1441 (alkyl C–H) cm–1. MS
2072
www.eurjoc.org
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2011, 2066–2074